| 2026-05-06 | 8-K | 10.6 | SUBORDINATION AGREEMENT, DATED AS OF MAY 5, 2026, AMONG THE PARENT, THE AGENT AND THE COMPANY |
|---|
| 2026-05-06 | 8-K | 10.5 | SUPPLEMENT TO LOAN AND SECURITY AGREEMENT, DATED AS OF MAY 5, 2026, AMONG THE COMPANY, CITIUS SUB, THE AGENT AND THE LENDERS |
|---|
| 2026-05-06 | 8-K | 10.4 | LOAN AND SECURITY AGREEMENT, DATED AS OF MAY 5, 2026, AMONG THE COMPANY, CITIUS SUB, THE AGENT AND THE LENDERS |
|---|
| 2026-05-06 | 8-K | 10.3 | THIRD AMENDMENT TO PROMISSORY NOTE, DATED AS OF MAY 4, 2026, BETWEEN THE COMPANY AND THE PARENT |
|---|
| 2026-05-06 | 8-K | 10.2 | FORM OF WARRANT AMENDMENT AGREEMENT, DATED AS OF MAY 5, 2026, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE HOLDER SIGNATORY THERETO |
|---|
| 2026-05-06 | 8-K | 10.1 | FORM OF WARRANT INDUCEMENT AGREEMENT, DATED AS OF MAY 5, 2026, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE HOLDER SIGNATORY THERETO |
|---|
| 2025-12-10 | 8-K | 10.5 | AMENDMENT TO PROMISSORY NOTE, DATED DECEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC |
|---|
| 2025-12-10 | 8-K | 10.4 | FORM OF WARRANT AMENDMENT AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE INVESTOR SIGNATORY THERETO |
|---|
| 2025-12-10 | 8-K | 10.3 | FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO |
|---|
| 2025-12-10 | 8-K | 10.2 | FORM OF PIPE SECURITIES PURCHASE AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO |
|---|
| 2025-12-10 | 8-K | 10.1 | FORM OF REGISTERED DIRECT SECURITIES PURCHASE AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO |
|---|
| 2025-10-27 | 8-K | 10.1 | AMENDMENT TO THE CITIUS ONCOLOGY, INC. 2024 OMNIBUS STOCK INCENTIVE PLAN. |
|---|
| 2025-09-19 | 8-K | 10.1 | AMENDMENT TO THE CITIUS ONCOLOGY, INC. 2024 OMNIBUS STOCK INCENTIVE PLAN |
|---|
| 2025-09-10 | 8-K | 10.3 | AMENDMENT TO PROMISSORY NOTE, DATED SEPTEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC |
|---|
| 2025-09-10 | 8-K | 10.2 | FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF SEPTEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO |
|---|
| 2025-09-10 | 8-K | 10.1 | PLACEMENT AGENCY AGREEMENT, DATED AS OF SEPTEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND MAXIM GROUP LLC |
|---|
| 2025-07-18 | 8-K | 10.2 | SECURITIES PURCHASE AGREEMENT, DATED AS OF JULY 16, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASERS NAMED THEREIN |
|---|
| 2025-07-18 | 8-K | 10.1 | PLACEMENT AGENCY AGREEMENT, DATED AS OF JULY 16, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND MAXIM GROUP LLC |
|---|
| 2024-12-27 | 10-K | 10.3 | 2023 OMNIBUS STOCK INCENTIVE PLAN |
|---|
| 2024-08-16 | 8-K | 10.9 | PROMISSORY NOTE, DATED AUGUST 16, 2024, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC. |
|---|
| 2024-08-16 | 8-K | 10.8 | SIDE LETTER AGREEMENT, DATED AUGUST 12, 2024, BY AND BY AND AMONG CITIUS PHARMACEUTICALS, INC., CITIUS ONCOLOGY, INC., TENX KEANE ACQUISITION AND TENX MERGER SUB, INC |
|---|
| 2024-08-16 | 8-K | 10.2 | AMENDED AND RESTATED SHARED SERVICES AGREEMENT, DATED AS OF AUGUST 12, 2024, BY AND AMONG CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC |
|---|
| 2024-08-16 | 8-K | 10.1 | AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 12, 2024 BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE SIGNATORIES THERETO |
|---|
| 2024-08-05 | 8-K | 10.5 | 2024 Omnibus Stock Incentive Plan |
|---|
| 2024-07-19 | 8-K | 10.4 | Promissory Note, dated July 17, 2024, by and between TenX Keane Acquisition and Citius Pharmaceuticals, Inc. |
|---|
| 2024-06-18 | 8-K | 10.3 | Promissory Note, dated June 17, 2024 |
|---|
| 2024-05-21 | 8-K | 10.1 | Promissory Note, dated May 17, 2024 |
|---|
| 2024-04-29 | 8-K | 10.1 | Promissory Note, dated April 26, 2024 |
|---|
| 2024-01-18 | 8-K | 10.1 | Promissory Note, dated January 17, 2024 |
|---|
| 2023-10-24 | 8-K | 10.3 | Form of Amended and Restated Shared Services Agreement |
|---|
| 2023-10-24 | 8-K | 10.2 | Form of Amended and Restated Registration Rights Agreement |
|---|
| 2023-10-24 | 8-K | 10.1 | Sponsor Support Agreement, dated October 23, 2023, by and among 10XYZ Holdings LP, TenX Keane Acquisition, Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. |
|---|
| 2023-10-18 | 8-K | 10.1 | Promissory Note, dated October 18, 2023, issued by TenX Keane Acquisition to 10XYZ Holdings LP. |
|---|
| 2023-07-18 | 8-K | 10.1 | Promissory Note, dated July 18, 2023, issued by TenX Keane Acquisition to 10XYZ Holdings LP. |
|---|
| 2022-10-19 | 8-K | 10.4 | Private Placement Unit Subscription Agreement, dated October 13, 2022, by and between the Company and 10XYZ Holdings LP |
|---|
| 2022-10-19 | 8-K | 10.3 | Registration Rights Agreement, dated October 13, 2022, by and between the Company and 10XYZ Holdings LP |
|---|
| 2022-10-19 | 8-K | 10.2 | Investment Management Trust Agreement, dated October 13, 2022, by and between the Company and American Stock Transfer & Trust Company, LLC |
|---|
| 2022-10-19 | 8-K | 10.1 | Letter Agreement, dated October 13, 2022, by and among the Company, its officers and directors, and 10XYZ Holdings LP |
|---|